Neurocrine Bioscience buy Oppenheimer Holdings Inc.
Start price
18.03.24
/
50%
€128.35
Target price
18.03.25
€183.92
Performance (%)
-21.39%
End price
19.03.25
€100.90
Summary
This prediction ended on 19.03.25 with a price of €100.90. The prediction for Neurocrine Bioscience disappointed with a performance of -21.39%. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | 2.519% | 2.519% | -0.930% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Oppenheimer_Holdings for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $170.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Oppenheimer_Holdings for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€200.69
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€133.55
02.05.24
02.05.24
€201.87
02.05.25
02.05.25
-27.32%
03.05.25
03.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.95
24.04.24
24.04.24
€187.12
24.04.25
24.04.25
-29.44%
25.04.25
25.04.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€94.60
02.08.23
02.08.23
€137.10
02.08.24
02.08.24
47.73%
03.08.24
03.08.24